mgmcricommunitymed
18,660 views
48 slides
Mar 17, 2016
Slide 1 of 48
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
About This Presentation
Diabetes
Size: 1.52 MB
Language: en
Added: Mar 17, 2016
Slides: 48 pages
Slide Content
Dr S. Vijayalakshmi
Assistant Professor, Community Medicine
MGMCRI, Pondicherry
Framework
•Definition of Diabetes Mellitus
•Classification of Diabetes
•Epidemiological features
•Clinical features
•Diagnosis
•Management
•Prevention
Diabetes is an epidemic,
chronic metabolic disorder of multiple etiology
in which the body can’t metabolize carbohydrate, fats and
proteins
because of defects in insulin secretion and/or action.
Classification of Diabetes
Problem Statement
World
150 million cases
Expected to double by yr 2025
SEAR
30 million cases
Expected to triple by yr 2025
India
Prevalence 2.4%(rural),4.0-11.6%(urban)
Diabetes Capital of the world
(Source: WHO 2011 NCD country profile)
- industrialization
- socio-economic development
- population growth
- age structure
- urbanization
Reasons for rising prevalence in developing countries
Agent Host Environment
IDDM Age : <30 yrs- IDDM
>30 years- NIDDM
Sedentary life style
NIDDM Sex: both Low dietary fibres
Type 1 HLA-DR3, DR4Malnutrition
GDM Alcohol
Obesity stress
Viral infection- beta
cell destruction
EPIDEMIOLOGICAL FACTORS
Diagnosis of Pre-diabetes and Diabetes
TestFasting Plasma
Glucose (FPG)
Oral Glucose
Tolerance Test
(OGTT)
Random
Plasma
Glucose
(with
symptoms)
How
perfor
med
Blood glucose is
measured after at
least
an 8 hr fast
75 gm glucose load
(drink) is ingested
after at least an 8hr
fast, Blood glucose
is measured at 2
hrs
Blood
glucose is
measured
at any time
regardless
of eating
Normal< 110mg/dl < 140 mg/dl (7.8
mmol/L)
17
Diagnosis of Pre-diabetes and Diabetes
Test Fasting Plasma
Glucose (FPG)
Oral Glucose Tolerance
Test (OGTT)
Random
Plasma
Glucose
(with
symptoms)
Pre-
diabetes
IFG
110-125 mg/dl
Pre-
diabetes
IGT
140-199 mg/dl
(7.8-11 mmol/L)
Diabetes
Mellitus
≥ 126 mg/dl (7
mmol/L)
≥ 200mg/dl (11.1
mmol/L)
≥ 200mg/dl
(11.1
mmol/L)
(with
symptoms)
18
HbA1C
Percentage of HbA to which Glucose
is attached
Normal: <5.7 %
Pre-diabetic: 5.7-6.4 %
Diabetic: >6.5 %
Type I or Type II Diabetes Mellitus
Investigations during Follow up
1.Urine sugar,2 hr PP (once a week)
2.Blood Sugar-FBS,PPBS (once in 3-6 months)
3.Lipid profile (Once in a yr)
4.ECG (Once a yr)
5.Urine albumin
6.Blood Urea, Serum creatinine
7.Retinoscopy (Once in a yr)
8.Glycated Hb (Once in 3-6 months)
Management of diabetes mellitus
TREATMENT OF
DIABETES
DIET
LIFESTYLE
MODIFICATIONS
OHA INSULIN
Why Diet Management?
To control weight
To complete nutritional requirements
To maintain blood glucose levels in normal limits
To correct any associated blood lipid
abnormalities
Diet in Diabetes
Diet in diabetes
1.Calories from food
~55% from carbohydrate
~30% from fat
~15% from protein
2.Calorie calculation
Overweight (sedentary)- 20 kC/kg
Normal wt (sedentary)- 30 kC/kg
Normal wt (heavy worker)- 35 kC/kg
Underweight- 40 kC/kg
5. 4-5 small frequent meals
(Same amount, same time daily)
6. Almonds : to lower cholesterol level
7. Fruits: Take apple, guava
8. Avoid excessive salt
Lifestyle modifications
Regular exercise
Walking
Other aerobic exercises
Maintenance of weight
Stop smoking
Foot care
Oral anti-diabetic drugs
If satisfactory control is not possible with
Diet and Lifestyle changes alone
Sulfonylureas (Tolbutamide,Glibenclamide)
Biguanides (Metformin)
Alpha-glucosidase inhibitors (Acarbose)
Thiazolidinediones (Rosiglitazone,Pioglitazone)
Technique of injection
•Painless 30/31G needles
•Subcutaneous
–Abdomen
–Thighs
–Arms
•Patients should be trained
Insulin Therapy
•Subcutaneous
–~30 min for onset of action
–60-90 min for peak action
•Should be given 30 min BEFORE meals
•Start with small dose and increase as
needed
Complications of Insulin therapy
•Hypoglycemia
•Local
–Lipohypertrophy
–Injection site abscess
•Insulin resistance
–Insulin antibodies
•Weight gain
–In overdosage
–Insulin stimulates hunger
Primary Prevention
a. Population strategy
Primordial prevention
Weight maintenance
Diet
Exercise
b. High risk strategy
Avoid diabetogenic drugs (corticosteroids)
Reduce the factors causing atheroslerosis
(smoking,hypertension,high cholesterol)
Secondary Prevention:Targets for screening of
diabetes?
Asymptomatics with:
Targets for screening of diabetes?
1. History of gestational D.M or
delivery of infant weighing over 4.5 kg
2. Pregnant women
3. Adults with Tuberculosis
4. Persons on diabetogenic drugs like steroids,thiazide diuretics
5. Women with Polycystic Ovary Syndrome(PCOD/PCOS)
6. History of premature vascular disease
Symptomatics and:
Secondary Prevention
Early diagnosis and treatment
Maintain blood glucose level
Maintain ideal weight (Height in cm-100)
Blood pressure measurement
Routine blood glucose monitoring
Urine for ketones and proteins
Glycated Hb estimation
(6 monthly, should be <6%)
Secondary Prevention
Keep sugar in your pocket
Weight,Blood pressure measurement,Visual acuity
Feet care
Self Care: Adhere to diet,drugs,exercise,
investigations, periodic check–ups, recognition of
symptoms of hypoglycemia
Identification card with treatment details
44
Feet Care
Wash feet daily,dry them,inspect them,
sprinkle talcum powder
Avoid walking bare foot,even at home
Wear soft cotton socks and canvas shoes
Avoid tight fitting shoes,chappals
Cut nails carefully after bath
See for the sensations
Feet Care
Do not use hot water bottles or heating pads or any
electrical device for heating the feet
Do not use a pumice stone to remove callousness
Do not sit with your legs crossed
Do not use commercial wart or corn removers on
your feet
Feet Care
Do not perform "bathroom surgery" by using
razor blades or other sharp instruments on your feet
Do not ignore any(minor also) foot problem
Use cream or lotion that keeps your skin soft and
free of cracks
Regular Self Glucose Monitoring
Tertiary Prevention
Disability limitation if any disability
Diabetes clinic